286 related articles for article (PubMed ID: 26047759)
1. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
2. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
[TBL] [Abstract][Full Text] [Related]
5. Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system.
Chen YC; Chiang CF; Chen LF; Liang PC; Hsieh WY; Lin WL
Biomaterials; 2014 Apr; 35(13):4066-81. PubMed ID: 24513319
[TBL] [Abstract][Full Text] [Related]
6. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
[TBL] [Abstract][Full Text] [Related]
7. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
8. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Lee PY
Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
[TBL] [Abstract][Full Text] [Related]
11. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues.
Chen YC; Chiang CF; Chen LF; Liao SC; Hsieh WY; Lin WL
Biomaterials; 2014 Feb; 35(6):2051-65. PubMed ID: 24315575
[TBL] [Abstract][Full Text] [Related]
12. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
[TBL] [Abstract][Full Text] [Related]
13. Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood-brain barrier opening and local gene delivery.
Fan CH; Chang EL; Ting CY; Lin YC; Liao EC; Huang CY; Chang YC; Chan HL; Wei KC; Yeh CK
Biomaterials; 2016 Nov; 106():46-57. PubMed ID: 27544926
[TBL] [Abstract][Full Text] [Related]
14. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.
Zhao G; Huang Q; Wang F; Zhang X; Hu J; Tan Y; Huang N; Wang Z; Wang Z; Cheng Y
Cancer Lett; 2018 Apr; 418():147-158. PubMed ID: 29339208
[TBL] [Abstract][Full Text] [Related]
15. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
[TBL] [Abstract][Full Text] [Related]
16. Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure.
McMahon D; Oakden W; Hynynen K
Theranostics; 2020; 10(4):1604-1618. PubMed ID: 32042325
[No Abstract] [Full Text] [Related]
17. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound enhanced delivery of macromolecular agents in brain tumor rat model.
Yang FY; Horng SC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5573-6. PubMed ID: 22255602
[TBL] [Abstract][Full Text] [Related]
19. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
Jung B; Huh H; Lee EH; Han M; Park J
J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
[TBL] [Abstract][Full Text] [Related]
20. Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model.
Arsiwala TA; Sprowls SA; Blethen KE; Fladeland RA; Wolford CP; Kielkowski BN; Glass MJ; Wang P; Wilson O; Carpenter JS; Ranjan M; Finomore V; Rezai A; Lockman PR
Fluids Barriers CNS; 2022 Sep; 19(1):72. PubMed ID: 36076213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
